TNFSF14 binding to T cell-containing bis-specific antibodies can generate anti-colorectal cancer immunity, inhibit colorectal cancer metastasis, and thus treat colorectal cancer based on IC [31]. Here, TNFSF14 is linked to colorectal cancer.